Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 702
Selected: 0
NCT IDTitle
NCT00594165An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.
NCT03248531A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
NCT00621959A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
NCT00362141Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
NCT00938431A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures
NCT00544388Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects
NCT04782388Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants
NCT02408549Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures
NCT01390220Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
NCT03992196A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome
NCT00843778Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
NCT00105040A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
NCT03993847CLassification of Axial SpondyloarthritiS Inception Cohort
NCT06617325A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT03204474A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects
NCT00160615Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
NCT01405508Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
NCT00419393Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures
NCT01063764An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
NCT03536884A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00619801Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin
NCT00600509Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
NCT01577264Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)
NCT00150774Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults
NCT02718716Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia
NCT03478982Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
NCT01964573Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
NCT00894231Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis
NCT00464269Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
NCT01592110A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
NCT01498120Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
NCT01458522Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures
NCT00614029A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
NCT00139880A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease
NCT00315523Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
NCT05292131A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants
NCT02495844A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
NCT01449071Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)
NCT01797224OTIS Cimzia Pregnancy Registry
NCT01087788Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
NCT00438451Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs
NCT02477839Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
NCT00510783IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
NCT07655375Study Evaluating the Effect of UCB8600 on Mast Cell Activation in the Human Gut
NCT00884325Management of Pruritus With Xyzal in Atopic Dermatitis
NCT00674362Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
NCT00381758The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting
NCT00175955Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
NCT00227461Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
NCT04666610A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy